Venture Leaders Biotech 2021
The Venture Leaders – the members of the Swiss National Startup Team – have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The Venture Leaders’ startup development program is specifically structured to help them achieve these goals. This intense journey offers 10 selected entrepreneurs an accelerated learning curve and a solid network through their exchanges with their peers in the team, as well as market exposure, feedback from investors and experts, and hands-on business development.
Venture Leaders Life Sciences alumni comprise high-flying startups such as Covagen (acquired by Johnson&Johnson), Redbiotec (partly acquired by Pfizer), KB Medical(acquired by Globus Medical), SimplicityBio (acquired by Precision for Medicine), AMAL Therapeutics (acquired by Boehringer Ingelheim) and Interax Biotech (Seed round with US investors met during the roadshow). Following these great success stories, Medtech and Biotech now have separate Venture Leaders programs, catering perfectly to the needs of entrepreneurial teams in the fields.
Eligibility
- You belong to the top Biotech startups in Switzerland and want to boost your future? Then apply to be one of the 10 members of the 2021 Swiss National Startup Team Biotech for a rocking week in China-the hotspot for health science and biotech. Don’t miss the opportunity!
Benefits
- Biz Dev, Fundraising, Networking, International.
Application process
Fee information: Varies